Please Wait.....
Report
Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-11-24 I 145 Pages I IMARC Group
The global human microbiome market size reached US$ 679.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,058.5 Million by 2028, exhibiting a growth rate (CAGR) of 20.30% during 2022-2028.
The human microbiome refers to the genes present inside various microorganisms found in the genetic portrait, or metagenome, of humans. It consists of various microorganisms, such as bacteria, fungi, protozoans, non-living viruses and numerous single-celled organisms. These organisms impact human physiology and contribute to the enhancement or impairment of metabolic and immune functions. They are found in the human tissues and are studied for medical advancements and analytical techniques. Microbiomes are utilized in probiotics, prebiotics, pharmaceutical drugs and diagnostic and therapeutic systems for various ailments, such as diabetes, obesity, cancer and metabolic, gastrointestinal, neurological, central nervous system and autoimmune disorders.
Human Microbiome Market Trends:
The increasing prevalence of chronic lifestyle diseases and infections due to microbial dysbiosis across the globe is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. The growth of the market can also be attributed to the increasing emphasis on the development of human microbiome therapeutics with enhanced efficacy. For instance, human gut microbiomes are being developed in specific combinations for the effective treatment of various gastrointestinal ailments. In line with this, the onset of the coronavirus (COVID-19) pandemic is also providing a thrust to the market growth. Researchers are extensively studying the lung microbiomes to analyze the severity of the infections and develop appropriate therapeutics and vaccines. Additionally, various advancements, such as the development of target-specific microbiome-based therapies, are also favoring the growth of the market. Other factors, including extensive research and development (R&D) activities, along with significant growth in the pharmaceutical industry, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global human microbiome market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and disease type.
Breakup by Product:
Probiotics
Prebiotics
Diagnostic Tests
Drugs
Medical Food
Others
Breakup by Application:
Therapeutics
Diagnostics
Breakup by Disease Type:
Obesity
Diabetes
Autoimmune Disorders
Cancer
Gastrointestinal Disorders
Central Nervous System Disorders
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 4D pharma plc, Atlas Biomed Group Limited, BIOHM, BiomX, Bione, DayTwo Inc., ENTEROME, Ferring B.V., Finch Therapeutics, Second Genome Inc., SynBioBeta LLC, Synthetic Biologics Inc., Vedanta Biosciences Inc. and Viome Inc.
Key Questions Answered in This Report:
How has the global human microbiome market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global human microbiome market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the disease type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global human microbiome market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Human Microbiome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Probiotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Prebiotics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Diagnostic Tests
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Drugs
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Medical Food
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Application
7.1 Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostics
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Disease Type
8.1 Obesity
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diabetes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Autoimmune Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Gastrointestinal Disorders
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Central Nervous System Disorders
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 4D pharma plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Atlas Biomed Group Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 BIOHM
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 BiomX
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Bione
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 DayTwo Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 ENTEROME
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Ferring B.V.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Finch Therapeutics
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Second Genome Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 SynBioBeta LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Synthetic Biologics Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Vedanta Biosciences Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.14 Viome Inc.
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
Figure 1: Global: Human Microbiome Market: Major Drivers and Challenges
Figure 2: Global: Human Microbiome Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Human Microbiome Market: Breakup by Product (in %), 2022
Figure 5: Global: Human Microbiome Market: Breakup by Application (in %), 2022
Figure 6: Global: Human Microbiome Market: Breakup by Disease Type (in %), 2022
Figure 7: Global: Human Microbiome Market: Breakup by Region (in %), 2022
Figure 8: Global: Human Microbiome (Probiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Human Microbiome (Probiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Human Microbiome (Prebiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Human Microbiome (Prebiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Human Microbiome (Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Human Microbiome (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Human Microbiome (Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Human Microbiome (Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Human Microbiome (Medical Food) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Human Microbiome (Medical Food) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Human Microbiome (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Human Microbiome (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Human Microbiome (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Human Microbiome (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Human Microbiome (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Human Microbiome (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Human Microbiome (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Human Microbiome (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Human Microbiome (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Human Microbiome (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Human Microbiome (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Human Microbiome (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Human Microbiome (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Human Microbiome (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Human Microbiome (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Human Microbiome (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Human Microbiome (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Human Microbiome (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Human Microbiome (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Human Microbiome (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Human Microbiome Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Human Microbiome Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Human Microbiome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Human Microbiome Industry: SWOT Analysis
Figure 88: Global: Human Microbiome Industry: Value Chain Analysis
Figure 89: Global: Human Microbiome Industry: Porter's Five Forces Analysis
Table 1: Global: Human Microbiome Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Human Microbiome Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Human Microbiome Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Human Microbiome Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 5: Global: Human Microbiome Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Human Microbiome Market: Competitive Structure
Table 7: Global: Human Microbiome Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security